DAIC

JUNE 4, 2024

Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. The CaRi-Heart technology is in clinical use in the UK, European Union, and Australia.

Technology 116

Technology Heart attacks Heart Attack Coronary Artery Disease 116

DAIC

JANUARY 18, 2024

Highlights from "Addressing Structural Racism Through Public Policy Advocacy: A Policy Statement from the American Heart Association" include: - During the past few years, the largest increases in cardiovascular disease deaths were among Asian, Black and Hispanic adults in the U.S. is tied to structural discrimination. -

Cardiovascular Disease 109

Cardiovascular Disease Health Disparities Education Public Health 109

DAIC

JANUARY 3, 2024

milla1cf Wed, 01/03/2024 - 12:09 January 3, 2024 — iRhythm Technologies, Inc. , The EU MDR is arguably one of the most stringent regulatory frameworks for product approvals globally that ensures medical devices meet the rigorous standards for healthcare technologies,” said Quentin Blackford, iRhythm President and Chief Executive Officer.

Technology 98

Technology Certification Arrhythmia Electrocardiogram 98

Frontiers in Cardiovascular Medicine

FEBRUARY 15, 2024

Background With the rapid development of technology, artificial intelligence (AI) has been widely used in the diagnosis and prognosis prediction of a variety of diseases, including cardiovascular disease. Facts have proved that AI has broad application prospects in rapid and accurate diagnosis.

Cardiovascular Disease 64

Cardiovascular Disease Article Research Cardiovascular Imaging 64

HCPLive

SEPTEMBER 25, 2024

A Q&A with Nihar Desai, MD, on the PROMPT-Lipid trial and the potential of advancing technology for improving patient care in pragmatic ways.

Technology 52

Technology Cardiovascular Disease Patient Care 52

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Recently, the use of assisted reproductive technology (ART) has rapidly increased. Moreover, emerging evidence suggests an increased risk of cardiovascular disease (CVD) in offspring conceived using ART. As a result, an increasing number of people are concerned about the safety of offspring produced through ART.

Technology 59

Technology Cardiovascular Disease Risk Factors 59

DAIC

JANUARY 25, 2024

Getty Images milla1cf Thu, 01/25/2024 - 20:44 January 25, 2024 — Agepha Pharma , a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment ( LODOCO – colchicine, 0.5 mg tablets for therapeutic intervention. mg tablets.”

Heart attacks 110

Heart attacks Heart Attack Technology Cardiovascular Disease 110

DAIC

JANUARY 17, 2024

Christian Tesche (Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina and Department of Cardiology, Munich University Clinic, Ludwig-Maximilian-University).

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

Science Daily - Heart Disease

JULY 25, 2024

3D-printed blood vessels, which closely mimic the properties of human veins, could transform the treatment of cardiovascular diseases.

Outcomes 108

Outcomes Cardiovascular Disease Technology 108

Med Page Today

DECEMBER 24, 2024

(MedPage Today) -- Use of assisted reproductive technology (ART) was not significantly associated with an increased long-term risk of cardiovascular diseases in women, according to a meta-analysis. European Heart Journal) A randomized trial in.

TAVR 84

TAVR Cardiovascular Disease Technology 84

Circulation

FEBRUARY 25, 2024

RNA therapeutics hold significant promise in the treatment of cardiovascular diseases. RNA-based therapies are becoming more common as a treatment modality for cardiovascular disease. mRNA technology may provide the platform for the expression of paracrine factors for myocardial protection and regeneration.

COVID-19 102

COVID-19 Cardiovascular Disease Blood Pressure Technology 102

DAIC

MAY 10, 2024

milla1cf Fri, 05/10/2024 - 08:17 May 10, 2024 — With cardiovascular disease being a leading cause of mortality worldwide, Vivalink , a leading provider of digital healthcare solutions, announces the launch of its comprehensive technology solution designed for Mobile Cardiac Telemetry (MCT) and Holter monitoring.

Technology 105

Technology Arrhythmia Heart Rhythm Cardiovascular Disease 105

DAIC

JUNE 4, 2024

milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.

Medicare 104

Medicare Plaque Reimbursement Cardiovascular Disease 104

Frontiers in Cardiovascular Medicine

APRIL 4, 2024

On this state of the art, we summarize the available literature on the effectiveness of virtual reality on various physical and psychological outcomes in patients with atherosclerotic cardiovascular disease.

Cardiovascular Disease 49

Cardiovascular Disease Cardiac Rehabilitation Interventional Cardiology Technology 49

DAIC

OCTOBER 29, 2024

The investigators shared the first randomized controlled trial (RCT) of FFRangio outcomes compared to invasive wire-based fractional flow reserve (FFR) has met its primary endpoint and revealed significant economic and resource utilization advantages for the non-invasive FFRangio technology over traditional wire-based approaches.

Technology 52

Technology Physiology Coronary Artery Disease Hospital 52

DAIC

JULY 16, 2024

mtaschetta-millane Tue, 07/16/2024 - 09:59 July 16, 2024 — Arineta , a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly announces the latest installation of its SpotLight Duo at Cardiovascular Consultants, Ltd. (CVC) CVC) in Arizona. sec per rotation.

Technology 105

Technology Heart Disease Cardiovascular Imaging Cardiovascular Disease 105

DAIC

FEBRUARY 28, 2024

The new scientific statement, “Use of Artificial Intelligence in Improving Outcomes in Heart Disease,” comes amid intense attention on AI as a way to improve cardiovascular disease prevention, detection, diagnosis and treatment. to ensure safety and effectiveness to mitigate harm as technologies rapidly evolve.

Best Practices 111

Best Practices Technology Cardiovascular Disease Stroke 111

DAIC

MAY 14, 2024

The collaboration seeks to provide access to emerging technologies, like Medis QFR, while also reducing complexity in the cath lab to improve the operating environment for clinicians.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

JUNE 14, 2024

Positron joins forces with the coalitions founding members, Bracco Diagnostics , CDL Nuclear Technologies and Siemens Healthcare who have come together to promote federal policies that advance health outcomes for patients with cardiovascular disease and improve the availability of cardiac PET diagnostics throughout the United States.

Reimbursement 105

Reimbursement Technology Innovation Education 105

Medical Xpress - Cardiology

FEBRUARY 22, 2024

Too often, the first sign of cardiovascular disease may be a major event like a heart attack, stroke or cardiac arrest.

Cardiac Arrest 81

Cardiac Arrest Heart Disease Heart attacks Heart Attack 81

American College of Cardiology

DECEMBER 18, 2023

In 2023, we continued to see advances in global health technology. These technologies provide a means to prevent, diagnose and treat cardiovascular disease and may also hold the keys to addressing health equity and improving clinician well-being.

Technology 75

Technology Cardiovascular Disease Article 75

DAIC

FEBRUARY 1, 2024

iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio monitor and ZEUS System 3. Novel AI Platform Matches Cardiologists in Detecting Rheumatic Heart Disease 7. Chung-Ang University Study Looks at Cardiovascular Risks in COVID-19 Survivors 8.

COVID-19 105

COVID-19 Heart Rhythm Cardiovascular Disease Technology 105

DAIC

JULY 18, 2024

About Kardia 12L ECG and KAI 12L AI Technology Kardia 12L ECG System combines the power of KAI 12L's AI technology and the pocket-sized Kardia 12L, to enable faster, easier detection of life-threatening cardiac conditions.

Reimbursement 105

Reimbursement Electrocardiogram Technology Medicaid 105

Journal of the American Heart Association

JANUARY 16, 2024

Cardiovascular diseases (CVDs) remain the leading cause of death and disability worldwide. Digital health technologies are important public health interventions for addressing the burden of cardiovascular disease. Journal of the American Heart Association, Volume 13, Issue 2 , January 16, 2024.

Technology 40

Technology Innovation Public Health Cardiovascular Disease 40

DAIC

JULY 25, 2024

The IVI is working towards a transition to a new kind of wellness and health system fueled and empowered by digital technologies. This concept, reported the company, is about using technology to develop preventative approaches that are 10 times more impactful than the current available solution.

Technology 105

Technology Exercise Innovation Quality of Life 105

DAIC

FEBRUARY 2, 2024

Cardiovascular disease is the leading cause of death globally - affecting millions of individuals and placing a significant burden on healthcare systems today. [1] million people died from cardiovascular diseases in 2019. million people in the United States by 2050 and 17.9 million in Europe by 2060. [2]

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 1 To date, interventional treatment of coronary artery disease with drug-eluting stents has been able to establish flow angiographically. of the U.S. population.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

DECEMBER 9, 2023

Dr. Aditya Sharma Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. Case review of use of the ACIST CVi Contrast Delivery System in high risk patient.

Webinar 105

Webinar Interventional Cardiology Best Practices Risk Factors 105

DAIC

JULY 18, 2024

Kolossváry added, “The PRE-VUE registry will empower us to see the true additive value of CT-derived, histologically validated plaque volumes in predicting future adverse cardiovascular events.” 2017 23, April 2020; Available from: [link]. Hafiane, Vulnerable plaque, characteristics, detection, and potential therapies , J.

Plaque 105

Plaque Heart attacks Heart Attack Cardiovascular Disease 105

DAIC

OCTOBER 1, 2024

Food and Drug Administration (FDA) for its PlaqueIQ imaging analysis software to help physicians diagnose cardiovascular disease (CVD). Elucid has announced it received 510(k) clearance from the U.S. Hafiane, Vulnerable plaque, characteristics, detection, and potential therapies , J. Cardiovasc. 6 (3) (2019).

Cardiovascular Disease 52

Cardiovascular Disease Plaque Quality of Life Myocardial Infarction 52

Frontiers in Cardiovascular Medicine

JUNE 28, 2024

Transesophageal Echocardiography (TEE) is an important imaging method for the evaluation of cardiac structure and function, and it holds significant value in the clinical management of cardiovascular diseases.

Article 75

Article Cardiovascular Disease Technology 75

DAIC

JULY 10, 2024

In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovascular disease (CVD). CVD is among the most prevalent diseases in the U.S., This includes artificial intelligence (AI), remote monitoring, virtual care, and other emerging technological advancements.

Technology 106

Technology Best Practices AFIB Patient Care 106

DAIC

JUNE 25, 2024

This advanced imaging technology allows me and my fellow clinicians to perform complex cardiology interventions with a high level of precision and exceptional image quality,” said Sean Mazer , M.D., According to the 2024 Heart Disease and Stroke Statistics: A Report of U.S. It’s an honor to have the U.S.’s

Electrophysiology 105

Electrophysiology Hospital Aortic valve Heart Disease 105

DAIC

JULY 15, 2024

He added, “Adding Story Health to our ecosystem both allows providers to exceed their care quality goals and ensures patients aren’t waiting to receive ongoing care, especially between visits when they may have higher disease burden or complications that can lead to expensive emergency department visits.

Technology 105

Technology Innovation Nursing Heart Failure 105

DAIC

MARCH 18, 2024

announced that the CLAAS System was featured in a podium presentation at the Cardiovascular Research Technologies (CRT) 2024 conference. milla1cf Mon, 03/18/2024 - 07:00 March 18, 2024 — Conformal Medical, Inc.

Cardiovascular Interventions 105

Cardiovascular Interventions Cardiovascular Disease Technology Research 105

DAIC

JULY 31, 2024

In its announcement about the workbook, ACC noted that cardiologists use digital devices and wearable technology to remotely monitor their patients for a variety of chronic cardiovascular diseases, including heart failure, coronary artery disease, vascular disease and atrial fibrillation.

Reimbursement 98

Reimbursement Technology Coronary Artery Disease Best Practices 98

DAIC

APRIL 5, 2024

Following the close of the transaction, Johnson & Johnson MedTech will be a category leader in four high-growth cardiovascular segments. Shockwave is a leading, first-to-market provider of innovative intravascular lithotripsy (IVL) technology for the treatment of calcified CAD and PAD.

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105